Zhao Wanchen, Wang Liqing, Zhang Meihong, Liu Zhiqi, Wu Chuanbin, Pan Xin, Huang Zhengwei, Lu Chao, Quan Guilan
State Key Laboratory of Bioactive Molecules and Druggability Assessment Jinan University Guangzhou China.
College of Pharmacy Jinan University Guangzhou China.
MedComm (2020). 2024 Jun 22;5(7):e603. doi: 10.1002/mco2.603. eCollection 2024 Jul.
Photodynamic therapy (PDT) is a temporally and spatially precisely controllable, noninvasive, and potentially highly efficient method of phototherapy. The three components of PDT primarily include photosensitizers, oxygen, and light. PDT employs specific wavelengths of light to active photosensitizers at the tumor site, generating reactive oxygen species that are fatal to tumor cells. Nevertheless, traditional photosensitizers have disadvantages such as poor water solubility, severe oxygen-dependency, and low targetability, and the light is difficult to penetrate the deep tumor tissue, which remains the toughest task in the application of PDT in the clinic. Here, we systematically summarize the development and the molecular mechanisms of photosensitizers, and the challenges of PDT in tumor management, highlighting the advantages of nanocarriers-based PDT against cancer. The development of third generation photosensitizers has opened up new horizons in PDT, and the cooperation between nanocarriers and PDT has attained satisfactory achievements. Finally, the clinical studies of PDT are discussed. Overall, we present an overview and our perspective of PDT in the field of tumor management, and we believe this work will provide a new insight into tumor-based PDT.
光动力疗法(PDT)是一种在时间和空间上可精确控制、无创且具有潜在高效性的光疗方法。PDT的三个主要组成部分包括光敏剂、氧气和光。PDT利用特定波长的光激活肿瘤部位的光敏剂,产生活性氧物质,这些物质对肿瘤细胞具有致命性。然而,传统光敏剂存在诸如水溶性差、严重依赖氧气和靶向性低等缺点,并且光难以穿透深部肿瘤组织,这仍然是PDT临床应用中最艰巨的任务。在此,我们系统地总结了光敏剂的发展及其分子机制,以及PDT在肿瘤治疗中的挑战,突出了基于纳米载体的PDT在抗癌方面的优势。第三代光敏剂的发展为PDT开辟了新的视野,纳米载体与PDT之间的合作也取得了令人满意的成果。最后,讨论了PDT的临床研究。总体而言,我们对肿瘤治疗领域中的PDT进行了概述并阐述了我们的观点,我们相信这项工作将为基于肿瘤的PDT提供新的见解。